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Introduction
Pseudohypoaldosteronism type 1 (PHA1) is a rare inher-
ited disease characterized by resistance to the actions of
aldosterone. It was first described in 1958 by Cheek and
Perry, and common clinical manifestations include salt
wasting, hyperkalaemia, metabolic acidosis and elevated
plasma aldosterone levels in the neonatal period.
Objective
To describe clinical characteristics, laboratory features
and management of one Vietnamese patient with
pseudohypoaldosteron.
Subject and methods
Clinical features, biochemical finding, mutation analysis
and management in a 1 months-old-boy was studied.
Based on analysis of this patient’s clinical symptoms asso-
ciated with biochemical examination, the urinary steroid
metabolomics analysis was performed using gas chroma-
tography spectrometry and mutation analysis of
SCNN1A was performed using PCR & direct sequencing.
Results
Patient is the first child normal delivery with the gesta-
tion age of 41 weeks, birth weight of 3200 g, and onset of
the disease at 7 days of age. He presented with lost
weight, dehydration without vomit, diarrhea or hyperpig-
mentation. He was admitted with the features of cyano-
sis, allorhythmic, electrolyte imbalance with sodium of
119 mmol/l, potassium of 7.4 mmol/l. Investigation show
pH 7.26, PCO2 34 mmHg, PO2 110 mmHg, HCO-3
18mmol/l, BE -10, plasma 17OHP level: 2,4 ng/ml, tes-
tosterone level: 1.94 nmol/l, Cortisol 8am: 2662,8 pmol/l,
Ure 7.4 mmol/l, Creatinine 44.2 umol/l, Glucose
4.8 mmol/l. the urine steroid metabolomics analysis
showed extensive excretion of aldosterone ID-ISTD1 of
1157.41 µg/l. Novel homozygous mutation (c.1668C>A;
p.S556R) of SCNN1A gene was identified in the proband.
He was treated with florinef of 0.1 mg/kg/day for electro-
lyte balance. He had complication of intestinal perfora-
tion and died due to infection. In conclusions, PHA1
causes severe hyponatremia, metabolic acidosis, and life-
threatening hyperkalemia, with normal 17-a-hydroxypro-
gesterone levels and high excretion of aldosterone levels
Written informed consent was obtained from the
patient’s parent or guardian for publication of this Case
report (and any accompanying images). A copy of the
written consent is available for review by the Editor-in-
Chief of this journal.
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